Member Info for Timster

Wouldn't want to be out this bank holiday weekend, ASCO around the corner, expecting strong buying with £1.37 by elevenses on Tuesday. Usual suspects on the bid of course.

What time is the Avacta presentation at ASCO?

"Can't see why thorn is still arguing the toss on that one."

Because he's a fluck1n moron!

usual adult dose for soft tissue sarcoma

note: several dosage regimens exist for this drug. the information presented here is manufacturer recommended dosing. some cancers are more responsive to this drug than others. always consult institutional protocol.as a single agent: 60 to 75 mg/m2 iv over 3 to 10 minutes every 21 days

the 21 days are there to allow recovery from a massive list of horrendous side effects, amongst which it's killing healthy heart tissue.

today's rns confirms that the first cohort which received 160 mg/m2 of ava6k over a two week period (i think that's higher than a standard dose of dox, bv wil confirm) have seen no adverse safety issues.

that in itself is remarkable, yes it's only 3 patients but if they had had straight dox then in my experience they would be in a terrible state.

the final cohort in the 3 week study was 3.5 times a standard dose. again amazing, with very limited side effects.

but of course today's message gets lost again in amongst the ******.

Ok ok I'll post the sealion link again

https://wondermark.com/c/1062/

Then buy my 3d sealion hoody

It's a bargain especially with ASCO round the corner, another MASSIVE ASCO incoming.....

If Avacta are attending I'd expect an RNS next week.

As I said when I started this thread which then became littered with green boxes:

While the cycle of endless fud has continued over the last few months ( and years) the trial has continued without any issues.

New diagnostic test tools are being used to identify FAP and the best indication to target.

Everything on target, new CEO. Apart from the SP Avacta couldn't be better placed

I don't richpaul I've filtered the three amigos and associated fluffers

doggy, yeah being a trader not an issue but dominating an investment board everyday posting ****** with the two other amigos is what ****es people off.

i'm guessing it's positive now, spot the pattern?

Perfect partnership.

In the future:

Patient diagnosed with cancer, scanned for FAP, results are mid to high.

Good news one of the pre|CISION chemotherapies will work for you, carry on with your life with a 2 weekly treatment plan and next to no side effects.

It's a clinical trial, maybe Google it.

While the cycle of endless fud has continued over the last few months ( and years) the trial has continued without any issues.

New diagnostic test tools are being used to identify FAP and the best indication to target.

Everything on target, new CEO apart from the SP Avacta couldn't be better placed.

The Sofie link was uncovered by one of the great board sluethers a long while ago and now it's officially announced.

The idiots are winning yet people still respond to them 😔

Thanks for the heads up, I was only just saying to the wife "I wonder what sworaf will do with his holding".

It's true point(now lilly) have canseek which is the first pre|CISION license. But it's preclinical and not the reason lilly bought them.

It's not though is it.

Your grasp of written English would place you in an Indian call centre watching. Hiding in plain sight, like Hurst!

Massive news for Avacta.